USPTO serial 88907218
ET HEALTH
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURDECKI, ANNA C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ET HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew T. Pettit
Andrew T. Pettit PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for reacting with biomolecules for scientific use; reagents for scientific use; reagents for reacting with biomolecules for research use; reagents for research use; diagnostic reagents for scientific research use; diagnostic reagents, buffers, and preparations, except for medical and veterinary use; biochemical reagents used for non-medical purposes for detecting and/or analyzing antigens, antibodies, proteins, ligands, or nucleotides; laboratory chemicals, namely, antibody reagents used for the detection of antigens or antibodies in liquid, cell, and tissue analysis for in vitro diagnostic use; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes | ACTIVE | — |
| 005 | Diagnostic reagents for medical use; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes | ACTIVE | — |
| 009 | Optical instruments for measuring a reaction by monitoring changes in the reflection of light, namely, interferometers; laboratory instruments in the nature of interferometers for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development; probes for scientific, research, or diagnostic purposes, not for medical or veterinary purposes; probes for scientific purposes, namely, probes to which biomolecules bind over the course of a scientific, research, or diagnostic procedure; interferometric sensors; probes for scientific purposes, namely, probes to which biomolecules bind during a scientific, research, or diagnostic procedure; probes for label-free analysis of assays being probes for scientific purposes; regenerable probes for scientific purpose, namely, probes for use in multiple scientific, research, or diagnostic procedures; downloadable computer software for scientific, research, or diagnostic analysis of interferometric measurements; downloadable computer software for scientific, research, or diagnostic analysis, namely, for performing antibody titer determination and isotyping; laboratory apparatus, namely, immunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; laboratory apparatus, namely, automated immunoassay analyzers for scientific, research, or diagnostic use, not for medical purposes | ACTIVE | — |
| 010 | Medical instruments, namely, diagnostic instruments for the analysis of body fluids through the measuring of light interference; medical diagnostic instruments for the analysis of body fluids through interferometry; medical diagnostic instruments for the analysis of biomolecules through interferometry; medical diagnostic tool in the nature of medical instruments for analyzing body fluids for investigating scientific questions and conducting tests; interferometers for medical use; interferometric sensors for medical use; probes for detecting and/or analyzing molecules in protein or nucleotide arrays for medical purposes; probes to which biomolecules bind during a medical procedure; probes for medical purposes for label-free analysis of assays; regenerable probes for use in multiple medical procedures; diagnostic kits consisting primarily of antibodies and reagents for use in disease testing for medical purposes; medical diagnostic apparatus, namely, immunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; medical diagnostic apparatus, namely, automated immunoassay analyzers for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Access Medical Systems
- Other trademarks owned by Access Medical Systems
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named ET HEALTH
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 12, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 12, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 10, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 10, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 10, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 23, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 23, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 23, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 10, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 13, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 27, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 5, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 10, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2020 | NWAP | NEW APPLICATION ENTERED | — |